Sources | Names Used |
---|---|
CTRPv2 | sirolimus:bortezomib (250:1 mol/mol) |
PharmacoGx | sirolimus:bortezomib (250:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AANAT | CTRPv2 | pan-cancer | AAC | 0.092 | 0.005 |
mRNA | ABC13-47488600E17.1 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.009 |
mRNA | ABCA5 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.007 |
mRNA | ABCA7 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
mRNA | ABCC4 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
mRNA | ABCD2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
mRNA | ABHD3 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | ABI1 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.006 |
mRNA | AC005281.1 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.008 |
mRNA | AC005338.1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |